Human induced pluripotent stem cell-derived mesenchymal progenitor cells

1 paper3 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Funders: Japan Science and Technology Agency and 3 more

Animals1

Outcomes

Anti-inflammatory cytokines

upin mice1

1 study

Human induced pluripotent stem cell-derived mesenchymal progenitor cells increase anti-inflammatory cytokines in mice.
“higher expression of anti-inflammatory cytokines than fibroblast tissues.”
Animalscompared to fibroblast tissuessubcutaneous
Human iPSC-derived mesenchymal progenitor cell sheets promote tissue formation after xenotransplantation
iScience11 Aug 2026

Latest

1 in 12 months

iScience20 Aug

Human iPSC-derived mesenchymal progenitor cell sheets promote tissue formation after xenotransplantation

Experiments in miceInterventions

Paper

Human induced pluripotent stem cell-derived mesenchymal progenitor cells

Outcomes

Latest

Human iPSC-derived mesenchymal progenitor cell sheets promote tissue formation after xenotransplantation

Related